| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.038 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.041 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.049 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.05 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |